Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan;14(1):e1758.
doi: 10.1002/wnan.1758. Epub 2021 Oct 12.

Surface modification of nano-drug delivery systems for enhancing antibiotic delivery and activity

Affiliations
Review

Surface modification of nano-drug delivery systems for enhancing antibiotic delivery and activity

Nawras Osman et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 Jan.

Abstract

Rampant antimicrobial resistance calls for innovative strategies to effectively control bacterial infections, enhance antibacterial efficacy, minimize side effects, and protect existing antibiotics in the market. Therefore, to enhance the delivery of antibiotics and increase their bioavailability and accumulation at the site of infection, the surfaces of nano-drug delivery systems have been diversely modified. This strategy applies various covalent and non-covalent techniques to introduce specific coating materials that have been found to be effective against various sensitive and resistant microorganisms. In this review, we discuss the techniques of surface modification of nanocarriers loaded with antibacterial agents. Furthermore, saccharides, polymers, peptides, antibiotics, enzymes and cell membranes coatings that have been used for surface functionalization of nano-drug delivery systems are described, emphasizing current approaches for enhancing delivery, bioavailability, and efficacy of surface-modified antibacterial nanocarriers at infection sites. This article offers a critical overview of the potential of surface-modified antibacterial nanocarriers to overcome the limitations of conventional antibiotics in the treatment of bacterial infections. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease Nanotechnology Approaches to Biology > Nanoscale Systems in Biology.

Keywords: antibacterial; bacteria; drug delivery; nanocarriers; surface modification.

PubMed Disclaimer

References

REFERENCES

    1. Abdelbary, G. (2011). Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharmaceutical Development and Technology, 16(1), 44-56. https://doi.org/10.3109/10837450903479988
    1. Ahmad, N., Ahmad, R., Alam, M. A., & Ahmad, F. J. (2018). Quantification and brain targeting of eugenol-loaded surface modified nanoparticles through intranasal route in the treatment of cerebral ischemia. Drug Research, 68(10), 584-595. https://doi.org/10.1055/a-0596-7288
    1. Ahmed, A., Sarwar, S., Hu, Y., Munir, M. U., Nisar, M. F., Ikram, F., Asif, A., Rahman, S. U., Chaudhry, A. A., & Rehman, I. U. (2021). Surface-modified polymeric nanoparticles for drug delivery to cancer cells. Expert Opinion on Drug Delivery, 18(1), 1-24. https://doi.org/10.1080/17425247.2020.1822321
    1. Angsantikul, P., Thamphiwatana, S., Zhang, Q., Spiekermann, K., Zhuang, J., Fang, R. H., Gao, W., Obonyo, M., & Zhang, L. (2018). Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against Helicobacter pylori infection. Advanced Therapeutic, 1(2), 1800016. https://doi.org/10.1002/adtp.201800016
    1. Arora, D., Sharma, N., Sharma, V., Abrol, V., Shankar, R., & Jaglan, S. (2016). An update on polysaccharide-based nanomaterials for antimicrobial applications. Applied Microbiology and Biotechnology, 100(6), 2603-2615. https://doi.org/10.1007/s00253-016-7315-0

Publication types

Substances

LinkOut - more resources